Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Free Cash Flow: 2012-2025

Historic Free Cash Flow for Phibro Animal Health (PAHC) over the last 14 years, with Jun 2025 value amounting to $41.8 million.

  • Phibro Animal Health's Free Cash Flow fell 248.21% to -$4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.3 million, marking a year-over-year decrease of 15.70%. This contributed to the annual value of $41.8 million for FY2025, which is 9.76% down from last year.
  • According to the latest figures from FY2025, Phibro Animal Health's Free Cash Flow is $41.8 million, which was down 9.76% from $46.4 million recorded in FY2024.
  • Over the past 5 years, Phibro Animal Health's Free Cash Flow peaked at $46.4 million during FY2024, and registered a low of -$38.5 million during FY2023.
  • Over the past 3 years, Phibro Animal Health's median Free Cash Flow value was $41.8 million (recorded in 2025), while the average stood at $16.6 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first tumbled by 613.33% in 2023, then surged by 220.46% in 2024.
  • Yearly analysis of 5 years shows Phibro Animal Health's Free Cash Flow stood at $19.0 million in 2021, then tumbled by 128.42% to -$5.4 million in 2022, then tumbled by 613.33% to -$38.5 million in 2023, then soared by 220.46% to $46.4 million in 2024, then declined by 9.76% to $41.8 million in 2025.